Fairmount Funds Management LLC

Insider

Director, 10% Owner

Trades at: APGE· JBIO· ORKA· CBIO· SYRE· VRDN· COGT· ZBIO +1 more

30D 90D 1Y

No open-market buys or sells in this period. The transactions below are grants, option exercises and gifts, which carry no market price.

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 30d

Open-market Buys Sells All types

No open-market buys or sells in this period — showing all activity (grants, exercises & gifts).

JBIO Grant·A
Jun 9, 26

Director, 10% Owner

$0

34.8K sh

Own New
APGE Grant·A
Jun 9, 26

Director

$0

7.7K sh

Own New
ORKA Grant·A
Jun 2, 26

Director, 10% Owner

$0

9.1K sh

Own New
CBIO Grant·A
Jun 2, 26

Director, 10% Owner

$0

11.1K sh

Own New
SYRE Grant·A
May 27, 26

Director

$0

8.0K sh

Own New

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
Jun 9, 2026	JBIO	Director, 10% Owner	Grant A	34.8K	New	—	$0
Jun 9, 2026	APGE	Director	Grant A	7.7K	New	—	$0
Jun 2, 2026	ORKA	Director, 10% Owner	Grant A	9.1K	New	—	$0
Jun 2, 2026	CBIO	Director, 10% Owner	Grant A	11.1K	New	—	$0
May 27, 2026	SYRE	Director	Grant A	8.0K	New	—	$0

Buy Sell Non-market (grant · exercise · gift)

About Fairmount Funds Management LLC

This profile aggregates every SEC Form 4 insider transaction reported by Fairmount Funds Management LLC across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.